About
Dr. Li Chen leads Hua Medicine, a drug discovery company whose mission is to bring clinically differentiated medicines to patients in China and worldwide. Before Dr. Chen founded Hua Medicine, he was the Chief Scientific Officer and Head of Research at Roche R&D Center (China) Ltd. and a member of Roche's Pharma Research Leadership Team. As a founding Director in this position, Li was responsible for development and implementation of China's drug discovery strategy, creation of the China discovery portfolio, and management of China operations including Biology, Chemistry, Pharmacology, Discovery Technology, Drug Supply and Drug Safety. He developed a "Collaborative Innovation" model through integration of over 100 scientist-based China partnerships with academic institutes, biotech, contract research organizations and clinical development organizations. During his 18 year pharma career, Li also had several leadership positions at Roche Nutley in New Jersey, including head of combin
Position in the VCSift Database
- • 1,913 investors hold the Founder & CEO role in VCSift. Li Chen is one of them.
- • 801 investors are based in Houston, Texas, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Houston, US
Contact Information
Find more investors like Li
Search Investors